Form 4: Sabra Health Care REIT Director Ann Kono Receives Restricted Stock Units

Director Ann Kono of Sabra Health Care REIT, Inc. reports the acquisition of restricted stock units and deferred stock units.

Summary

• On June 13, 2024, Ann Kono, a director of Sabra Health Care REIT, Inc., acquired 9,480 shares of common stock through the grant of restricted stock units.
• These units vest in equal monthly installments starting July 13, 2024, and ending on the earlier of June 13, 2025, or the day before the next annual stockholders' meeting.
• Kono also holds 35,663 stock units that have vested but the payment of which has been deferred.
• The filing also includes a Power of Attorney, effective June 13, 2024, granting authority to Richard K. Matros, Michael Costa, Andor D. Terner, Shelly Heyduk, Mollie Yeh, and Regina Braman to act on Kono's behalf for SEC filings related to Sabra Health Care REIT, Inc.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management interests with shareholders. The sentiment is moderately positive due to the alignment of interests.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It reflects standard practices for aligning management interests with shareholder value through equity-based compensation.

Comparison to Industry Standards

• Equity compensation is a common practice among publicly traded REITs to incentivize executives and align their interests with those of shareholders.
• Vesting schedules for restricted stock units typically range from one to five years, with monthly or quarterly vesting being fairly standard.
• Deferred compensation plans are also common, allowing executives to defer income and potentially reduce their current tax burden.

Stakeholder Impact

• Shareholders may view the grant of restricted stock units positively as it incentivizes the director to work towards increasing shareholder value.
• The Power of Attorney ensures that SEC filings are handled efficiently and in compliance with regulations.

Next Steps

• The restricted stock units will continue to vest monthly until June 13, 2025, or the day before the next annual stockholders' meeting.
• Future SEC filings will be required to report any further changes in Kono's beneficial ownership of Sabra Health Care REIT, Inc. stock.

Key Dates